• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

JAM3/PAX1甲基化在高危型人乳头瘤病毒感染女性高级别鳞状上皮内病变诊断中的表现

The performance of JAM3/PAX1 methylation in the diagnosis of high-grade squamous intraepithelial lesions for women with high-risk HPV infection.

作者信息

Sun Dan, Shu Changfa, Zeng Fei, Xu Dabao, Zhao Xingping

机构信息

Department of Gynecology, the Third Xiangya Hospital of Central South University, No.138 Tongzipo Road, Hunan, 410013, China.

The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.

出版信息

BMC Cancer. 2024 Dec 18;24(1):1514. doi: 10.1186/s12885-024-13299-y.

DOI:10.1186/s12885-024-13299-y
PMID:39696066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11658199/
Abstract

OBJECTIVE

To assess the clinical value of DNA methylation measurement in exfoliated cervical cells for distinguishing high-grade squamous intraepithelial lesions (HSIL) from other cervical abnormalities.

METHODS

A total of 276 patients were enrolled, and general clinical information was collected. Exfoliated cervical cells were obtained to assess human papillomavirus (HPV) infection, conduct ThinPrep cytology tests (TCT), and measure methylation levels of JAM3 (△CtJ) and PAX1 (△CtP). Logistic regression was performed to identify factors significantly associated with HSIL diagnosis. A conditional inference tree model and the area under the curve (AUC) were employed to evaluate the efficacy of JAM3 and PAX1 methylation in detecting HSIL.

RESULTS

Independent risk factors for HSIL diagnosis included △CtJ, △CtP, atypical squamous cells of undetermined significance (ASCUS), and HPV16 infection. The conditional inference tree indicated that 96.4% of patients were non-HSIL when △CtJ > 11.66, and 99.1% were non-HSIL when △CtP > 10.97. The diagnostic performance of △CtJ/△CtP surpassed that of TCT/HPV alone. Among six methods, the combination of △CtP, TCT, and high-risk HPV (hr-HPV) testing achieved the highest sensitivity (91.2%), positive predictive value (50.0%), negative predictive value (98.6%), and AUC (0.932).

CONCLUSION

In women with hr-HPV infection, DNA methylation analysis of cervical cytology outperformed traditional TCT or HPV testing. The combination of △CtP with TCT and HPV may offer the most accurate screening approach for HSIL.

摘要

目的

评估宫颈脱落细胞中DNA甲基化检测在鉴别高级别鳞状上皮内病变(HSIL)与其他宫颈异常方面的临床价值。

方法

共纳入276例患者,收集一般临床信息。获取宫颈脱落细胞以评估人乳头瘤病毒(HPV)感染情况、进行薄层液基细胞学检测(TCT),并检测JAM3(△CtJ)和PAX1(△CtP)的甲基化水平。采用逻辑回归分析确定与HSIL诊断显著相关的因素。使用条件推断树模型和曲线下面积(AUC)评估JAM3和PAX1甲基化检测HSIL的效能。

结果

HSIL诊断的独立危险因素包括△CtJ、△CtP、意义不明确的非典型鳞状细胞(ASCUS)和HPV16感染。条件推断树显示,当△CtJ>11.66时,96.4%的患者为非HSIL;当△CtP>10.97时,99.1%的患者为非HSIL。△CtJ/△CtP的诊断性能优于单独的TCT/HPV。在六种方法中,△CtP、TCT和高危型HPV(hr-HPV)检测联合使用时,灵敏度最高(91.2%),阳性预测值为(50.0%),阴性预测值为(98.6%),AUC为(0.932)。

结论

在hr-HPV感染的女性中,宫颈细胞学的DNA甲基化分析优于传统的TCT或HPV检测。△CtP与TCT和HPV联合使用可能为HSIL提供最准确的筛查方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/11658199/f5689b11a004/12885_2024_13299_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/11658199/85892c2ce2c7/12885_2024_13299_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/11658199/3d3743e6f8f4/12885_2024_13299_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/11658199/f5689b11a004/12885_2024_13299_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/11658199/85892c2ce2c7/12885_2024_13299_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/11658199/3d3743e6f8f4/12885_2024_13299_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/11658199/f5689b11a004/12885_2024_13299_Fig3_HTML.jpg

相似文献

1
The performance of JAM3/PAX1 methylation in the diagnosis of high-grade squamous intraepithelial lesions for women with high-risk HPV infection.JAM3/PAX1甲基化在高危型人乳头瘤病毒感染女性高级别鳞状上皮内病变诊断中的表现
BMC Cancer. 2024 Dec 18;24(1):1514. doi: 10.1186/s12885-024-13299-y.
2
A novel methylation-detection panel for HPV associated high-grade squamous intraepithelial lesion and cervical cancer screening.一种用于 HPV 相关高级别鳞状上皮内病变和宫颈癌筛查的新型甲基化检测面板。
Sci Rep. 2024 Oct 26;14(1):25556. doi: 10.1038/s41598-024-75047-3.
3
Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesions.接种人乳头瘤病毒疫苗的宫颈高级别鳞状上皮内病变女性中低甲基化标志物水平。
Int J Cancer. 2024 Nov 1;155(9):1549-1557. doi: 10.1002/ijc.35044. Epub 2024 May 27.
4
PAX1 methylation as a robust predictor: developing and validating a nomogram for assessing endocervical curettage (ECC) necessity in human papillomavirus16/18-positive women undergoing colposcopy.PAX1 甲基化作为一个强有力的预测指标:建立和验证一个列线图模型,以评估人乳头瘤病毒 16/18 阳性接受阴道镜检查的女性行宫颈管搔刮术(ECC)的必要性。
Clin Epigenetics. 2024 Jun 7;16(1):77. doi: 10.1186/s13148-024-01691-1.
5
Cervical cancer screening: efficacy of PAX1 and JAM3 methylation assay in the triage of atypical squamous cell of undetermined significance (ASC-US).宫颈癌筛查:PAX1 和 JAM3 甲基化检测在不明确意义的非典型鳞状细胞(ASC-US)病例分流中的功效。
BMC Cancer. 2024 Nov 11;24(1):1385. doi: 10.1186/s12885-024-13082-z.
6
Triage performance of DNA methylation for women with high-risk human papillomavirus infection.DNA甲基化对高危型人乳头瘤病毒感染女性的分诊表现
Oncologist. 2025 Mar 10;30(3). doi: 10.1093/oncolo/oyae324.
7
Comparing the performance of DeoxyriboNucleic Acid methylation analysis and cytology for detecting cervical (pre)cancer in women with high-risk human papillomavirus-positive status in a gynecologic outpatient population.比较脱氧核糖核酸甲基化分析与细胞学在妇科门诊人群中高危型人乳头瘤病毒阳性妇女中检测宫颈(前)癌的性能。
BMC Cancer. 2024 Nov 4;24(1):1352. doi: 10.1186/s12885-024-13126-4.
8
JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix.JAM3甲基化状态作为子宫颈癌前病变和肿瘤性病变诊断的生物标志物。
Oncotarget. 2015 Dec 29;6(42):44373-87. doi: 10.18632/oncotarget.6250.
9
Highgrade cervical lesions diagnosed by methylation in highrisk human papillomavirusinfected patients.高危型人乳头瘤病毒感染患者经甲基化诊断的高级别宫颈病变。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Dec 28;48(12):1820-1829. doi: 10.11817/j.issn.1672-7347.2023.230175.
10
PAX1/SOX1 DNA Methylation Versus Cytology and HPV16/18 Genotyping for the Triage of High-Risk HPV-Positive Women in Cervical Cancer Screening: Retrospective Analysis of Archival Samples.PAX1/SOX1 DNA甲基化与细胞学及HPV16/18基因分型在宫颈癌筛查中对高危HPV阳性女性进行分流的比较:存档样本的回顾性分析
BJOG. 2025 Jan;132(2):197-204. doi: 10.1111/1471-0528.17965. Epub 2024 Sep 26.

本文引用的文献

1
Triage performance of PAX1/JAM3 in opportunistic cervical cancer screening of non‒16/18 human papillomavirus-positive women: a multicenter prospective study in China.PAX1/JAM3 在非 16/18 型人乳头瘤病毒阳性妇女机会性宫颈癌筛查中的诊断效能:中国多中心前瞻性研究。
Clin Epigenetics. 2024 Aug 16;16(1):108. doi: 10.1186/s13148-024-01731-w.
2
Evaluating PAX1 methylation for cervical cancer screening triage in non-16/18 hrHPV-positive women.评估 PAX1 甲基化在非 16/18 型人乳头瘤病毒阳性妇女宫颈癌筛查中的分流作用。
BMC Cancer. 2024 Jul 29;24(1):913. doi: 10.1186/s12885-024-12696-7.
3
Cervical cancer screening using DNA methylation triage in a real-world population.
基于 DNA 甲基化的初筛在真实人群中进行宫颈癌筛查。
Nat Med. 2024 Aug;30(8):2251-2257. doi: 10.1038/s41591-024-03014-6. Epub 2024 Jun 4.
4
Highgrade cervical lesions diagnosed by methylation in highrisk human papillomavirusinfected patients.高危型人乳头瘤病毒感染患者经甲基化诊断的高级别宫颈病变。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Dec 28;48(12):1820-1829. doi: 10.11817/j.issn.1672-7347.2023.230175.
5
Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study.拉丁美洲原发性宫颈癌筛查中宫颈细胞学和HPV检测的性能:ESTAMPA研究中的一项分析
Lancet Reg Health Am. 2023 Sep 20;26:100593. doi: 10.1016/j.lana.2023.100593. eCollection 2023 Oct.
6
Testing for viral DNA integration among HPV-positive women to detect cervical precancer: An observational cohort study.检测 HPV 阳性女性的病毒 DNA 整合以检测宫颈癌前病变:一项观察性队列研究。
BJOG. 2024 Feb;131(3):309-318. doi: 10.1111/1471-0528.17597. Epub 2023 Jul 6.
7
Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.评价基于 HPV 初筛的 HPV 阳性自我采样标本中 DNA 甲基化生物标志物 ASCL1 和 LHX8 的应用。
Br J Cancer. 2023 Jul;129(1):104-111. doi: 10.1038/s41416-023-02277-z. Epub 2023 Apr 26.
8
Long-read sequencing unveils high-resolution HPV integration and its oncogenic progression in cervical cancer.长读测序揭示了宫颈癌中 HPV 整合的高分辨率及其致癌进展。
Nat Commun. 2022 May 10;13(1):2563. doi: 10.1038/s41467-022-30190-1.
9
Detection of Host Cell Gene/HPV DNA Methylation Markers: A Promising Triage Approach for Cervical Cancer.宿主细胞基因/人乳头瘤病毒DNA甲基化标志物的检测:一种有前景的宫颈癌筛查方法
Front Oncol. 2022 Mar 25;12:831949. doi: 10.3389/fonc.2022.831949. eCollection 2022.
10
HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection.尿液中HPV和DNA甲基化检测用于宫颈上皮内瘤变和宫颈癌的检测
Clin Cancer Res. 2022 May 13;28(10):2061-2068. doi: 10.1158/1078-0432.CCR-21-3710.